1
|
Shu L, Yang G, Liu S, Huang N, Wang R, Yang M, Chen C. A comprehensive review on arsenic exposure and risk assessment in infants and young children diets: Health implications and mitigation interventions in a global perspective. Compr Rev Food Sci Food Saf 2025; 24:e70063. [PMID: 39731717 DOI: 10.1111/1541-4337.70063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2024] [Revised: 09/29/2024] [Accepted: 10/23/2024] [Indexed: 12/30/2024]
Abstract
The early stages of human development are critical for growth, and exposure to arsenic, particularly through the placenta and dietary sources, poses significant health risks. Despite extensive research, significant gaps remain in our comprehension of regional disparities in arsenic exposure and its cumulative impacts during these developmental stages. We hypothesize that infants in certain regions are at greater risk of arsenic exposure and its associated health complications. This review aims to fill these gaps by providing a comprehensive synthesis of epidemiological evidence related to arsenic exposure during early life, with an emphasis on the underlying mechanisms of arsenic toxicity that contribute to adverse health outcomes, including neurodevelopmental impairments, immune dysfunction, cardiovascular diseases, and cancer. Further, by systematically comparing dietary arsenic exposure in infants across Asia, the Americas, and Europe, our findings reveal that infants in Bangladesh, Pakistan, and India, exposed to levels significantly exceeding the health reference value range of 0.3-8 µg/kg/day, are particularly vulnerable to dietary inorganic arsenic. This comparative analysis not only highlights geographic disparities in exposure but also underscores the variability in regulatory frameworks. Finally, the review identifies early life as a critical window for dietary arsenic exposure and offers evidence-based recommendations for mitigating arsenic contamination in infant foods. These strategies include improved agricultural practices, dietary modifications, stricter regulatory limits on arsenic in infant products, and encouragement of low-arsenic dietary alternatives. Our work establishes the framework for future research and policy development aimed at reducing the burden of arsenic exposure from source to table and effectively addressing this significant public health challenge.
Collapse
Affiliation(s)
- Lin Shu
- School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China
| | | | - Shufang Liu
- School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Nan Huang
- School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Ruike Wang
- School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Mengxue Yang
- School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China
| | - Chen Chen
- School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China
| |
Collapse
|
2
|
Li W, Chen X, Yao M, Sun B, Zhu K, Wang W, Zhang A. LC-MS based untargeted metabolomics studies of the metabolic response of Ginkgo biloba extract on arsenism patients. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY 2024; 274:116183. [PMID: 38471343 DOI: 10.1016/j.ecoenv.2024.116183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/01/2023] [Revised: 02/14/2024] [Accepted: 03/05/2024] [Indexed: 03/14/2024]
Abstract
Arsenic is an environmentally ubiquitous toxic metalloid. Chronic exposure to arsenic may lead to arsenicosis, while no specific therapeutic strategies are available for the arsenism patients. And Ginkgo biloba extract (GBE) exhibited protective effect in our previous study. However, the mechanisms by which GBE protects the arsenism patients remain poorly understood. A liquid chromatography-mass spectrometry (LC-MS) based untargeted metabolomics analysis was used to study metabolic response in arsenism patients upon GBE intervention. In total, 39 coal-burning type of arsenism patients and 50 healthy residents were enrolled from Guizhou province of China. The intervention group (n = 39) were arsenism patients orally administered with GBE (three times per day) for continuous 90 days. Plasma samples from 50 healthy controls (HC) and 39 arsenism patients before and after GBE intervention were collected and analyzed by established LC-MS method. Statistical analysis was performed by MetaboAnalyst 5.0 to identify differential metabolites. Multivariate analysis revealed a separation in arsenism patients between before (BG) and after GBE intervention (AG) group. It was observed that 35 differential metabolites were identified between BG and AG group, and 30 of them were completely or partially reversed by GBE intervention, with 14 differential metabolites significantly up-regulated and 16 differential metabolites considerably down-regulated. These metabolites were involved in promoting immune response and anti-inflammatory functions, and alleviating oxidative stress. Taken together, these findings indicate that the GBE intervention could probably exert its protective effects by reversing disordered metabolites modulating these functions in arsenism patients, and provide insights into further exploration of mechanistic studies.
Collapse
Affiliation(s)
- Weiwei Li
- Key Laboratory of Environmental Pollution, Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang 550025, PR China
| | - Xiong Chen
- Key Laboratory of Environmental Pollution, Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang 550025, PR China
| | - Maolin Yao
- Key Laboratory of Environmental Pollution, Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang 550025, PR China
| | - Baofei Sun
- Key Laboratory of Environmental Pollution, Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang 550025, PR China
| | - Kai Zhu
- Key Laboratory of Environmental Pollution, Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang 550025, PR China
| | - Wenjuan Wang
- Key Laboratory of Environmental Pollution, Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang 550025, PR China
| | - Aihua Zhang
- Key Laboratory of Environmental Pollution, Monitoring and Disease Control, Ministry of Education, Department of Toxicology, School of Public Health, Guizhou Medical University, Guiyang 550025, PR China.
| |
Collapse
|